Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States
BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V. (Nordic Pharma), announces the completion of its acquisition of Visant Medical, Inc.